121
Views
14
CrossRef citations to date
0
Altmetric
Drug Profile

Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications

&
Pages 23-34 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Albert J Czaja. (2012) Drug choices in autoimmune hepatitis: Part B – nonsteroids. Expert Review of Gastroenterology & Hepatology 6:5, pages 617-635.
Read now
Albert J Czaja. (2009) Current and future treatments of autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 3:3, pages 269-291.
Read now

Articles from other publishers (12)

Garth R Swanson, Mary Biglin, Hannah Raff, Vijit Chouhan, Sarah Jochum, Maliha Shaikh, Lauren Francey, Faraz Bishehsari, John Hogenesch & Ali Keshavarzian. (2022) IMPACT OF CHRONOTHERAPY ON 6-MERCAPTOPURINE METABOLITES IN INFLAMMATORY BOWEL DISEASE: A PILOT CROSSOVER TRIAL. Clinical and Translational Gastroenterology Publish Ahead of Print.
Crossref
瑞芳 胡. (2022) Clinical Research Progress of Infliximab Combined with Azathioprine in the Treatment of Inflammatory Bowel Disease. Advances in Clinical Medicine 12:12, pages 10987-10993.
Crossref
Albert J. Czaja. (2020) Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 51:12, pages 1286-1304.
Crossref
Julian Essmann, Carsten Keil, Olesya Unruh, Anita Otte, Michael P. Manns & Oliver Bachmann. (2019) Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn’s disease. European Journal of Gastroenterology & Hepatology 31:1, pages 99-108.
Crossref
Evangelos Messaris & Themistocles Dassopoulos. 2019. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 1888 1918 .
Sudeep Dhoj Thapa, Hiba Hadid, Mohammed Usman, Waseem Imam, Ahmad Hassan, Jason Schairer, Syed-Mohammed R. Jafri & Nirmal Kaur. (2015) Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients. Digestive Diseases and Sciences 61:1, pages 230-237.
Crossref
Sudeep D. Thapa, Hiba Hadid, Waseem Imam, Jason Schairer & Syed-Mohammed Jafri. (2015) Effect of Inflammatory Bowel Disease–Related Characteristics and Treatment Interventions on Cardiovascular Disease Incidence. The American Journal of the Medical Sciences 350:3, pages 175-180.
Crossref
Hongha T. Vu & Themistocles Dassopoulos. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 31 44 .
A. J. Czaja. (2013) Review article: the management of autoimmune hepatitis beyond consensus guidelines. Alimentary Pharmacology & Therapeutics 38:4, pages 343-364.
Crossref
Albert J. Czaja. (2010) Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis. Digestive Diseases and Sciences 55:10, pages 2712-2726.
Crossref
Donald J. AbrahamWilliam J. Pitts. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 983 1063 .
I. KÜBLER, M. J. KOSLOWSKI, M. GERSEMANN, K. FELLERMANN, J. BEISNER, S. BECKER, K. ROTHFUSS, K. R. HERRLINGER, E. F. STANGE & J. WEHKAMP. (2009) Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease. Alimentary Pharmacology & Therapeutics 30:6, pages 621-633.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.